7:46AM Trimeris and Synageva BioPharma announce merger agreement in the form of a stock-for-stock merger (TRMS) 2.84 : Synageva BioPharma, a privately held biopharmaceutical co developing therapeutic products for rare disorders, and Trimeris (TRMS), announce that they have entered into a definitive agreement under which Synageva will merge with Trimeris in an all-stock transaction. Upon closing, the combined co will be named Synageva BioPharma, and will operate under the leadership of the Synageva management team with Sanj Patel serving as the President and CEO. TRMS will issue to Synageva stockholders shares of Trimeris common stock such that Synageva stockholders will own ~75% of the combined co's shares outstanding, and Trimeris stockholders will own ~25%. Options and warrants of both Synageva and Trimeris will be assumed by the combined co and become options and warrants to acquire stock of the combined company.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM